Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.61 - $4.68 $14,111 - $41,020
-8,765 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.79 - $4.65 $1,104 - $2,869
-617 Reduced 6.58%
8,765 $37,000
Q4 2021

Feb 11, 2022

SELL
$4.11 - $15.13 $1,150 - $4,236
-280 Reduced 2.9%
9,382 $43,000
Q3 2021

Nov 12, 2021

BUY
$10.32 - $16.9 $60,630 - $99,287
5,875 Added 155.14%
9,662 $146,000
Q2 2021

Aug 13, 2021

BUY
$14.98 - $23.89 $838 - $1,337
56 Added 1.5%
3,787 $62,000
Q1 2021

May 07, 2021

BUY
$17.95 - $25.91 $66,971 - $96,670
3,731 New
3,731 $71,000

About NexImmune, Inc.


  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $5.07M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.